Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001203527 | SCV001374696 | likely benign | Ullrich congenital muscular dystrophy 2; Bethlem myopathy 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003163536 | SCV003889832 | uncertain significance | Inborn genetic diseases | 2023-03-06 | criteria provided, single submitter | clinical testing | The c.4280G>A (p.R1427H) alteration is located in exon 22 (coding exon 21) of the COL12A1 gene. This alteration results from a G to A substitution at nucleotide position 4280, causing the arginine (R) at amino acid position 1427 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |